NAFAMOSTAT
UNII Y25LQ0H97D

Substance Identification & Data

This profile provides standardized clinical and technical data for Nafamostat, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Y25LQ0H97D.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 81525-10-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Y25LQ0H97D

CAS Registry Number

81525-10-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

NAFAMOSTAT

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C19H17N5O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

MQQNFDZXWVTQEH-UHFFFAOYSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C96292

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

4413

Unique identification number in the NCBI database of chemical substances.

INN ID

5682

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

c1c2c(cc(cc2)C(N)=N)ccc1OC(c3ccc(cc3)NC(N)=N)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Nafamostat. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.